Lead party: Merck & Co., Inc. (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: ConnectMed Limited (private company) · Sector: Healthcare, Telemedicine Providers · Countries of operation: Kenya, South Africa
Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions, Venture Capital · Strategy: Acquisition, Venture Equity · Instrument: Equity
Lead investor/buyer: Merck & Co., Inc. · Investors/buyers: Merck & Co., Inc.
Legal advisers: not identified in the source record.
Source: announced 5 April 2019. Original announcement: disrupt-africa.com.


